PERLAS DE EMBOLIZACIÓN DCBEAD LUMI BOSTON SCIENTIFIC - COFEPRIS Registration 844R2021 SSA
Access comprehensive regulatory information for PERLAS DE EMBOLIZACIÓN DCBEAD LUMI BOSTON SCIENTIFIC (EMBOLIZATION BEADS DCBEAD LUMI BOSTON SCIENTIFIC) in the Mexico medical device market through Pure Global AI's free database. This Clase III medical device is registered under COFEPRIS analysis ID 844R2021 SSA and manufactured by BOSTONSCIENTIFICDEMÉXICO, S.A. DE C.V.. The device was registered on May 14, 2021.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
LAS PERLAS DC BEAD LUMI SE PUEDENUTILIZAR COMO AGENTE EMBÓLICO CON OSIN LA LIBERACIÓN DE DOXORRUBICINA OIRINOTECÁN. LASPERLASDCBEADLUMISINCARGATIENENCOMOFIN UTILIZARSEPARALA EMBOLIZACIÓN DE TUMORESHIPERVASCULARES NO MALIGNOS YMALFORMACIONES ARTERIOVENOSAS (AVM).PARA EL USO EN INDICIOS DE TUMORESMALIGNOS: •ELPRODUCTODCBEADLUMISEDESTINAPRINCIPALMENTEALUSOCOMOAGENTE EMBÓLICO PARA EL TRATAMIENTOLOCALDETUMORESHIPERVASCULARIZADOSMALIGNOS EN EL HÍGADO.
BEAD LUMI BEADS CAN BE USED AS AN EMBOLIC AGENT WITH OSIN RELEASING DOXORUBICIN OIRINOTECAN. THEPERLASDCBEADLUMISINCARGAARE INTENDED TO SEPARATE THE EMBOLIZATION OF NONMALIGNANT HYPERVASCULAR TUMORS AND ARTERIOVENOUS MALFORMATIONS (AVA). FOR USE IN SIGNS OF MALIGNANT TUMOURS: •THE PRODUCT DCBEADLUMISE IS MAINLY INTENDED FOR USE AS AN EMBOLIC AGENT FOR THE LOCAL TREATMENT OF MALIGNANT HYPERVASCULARISED TUMOURS IN THE LIVER.